The best way to survive cardiovascular disease is to not come down with it. Proper diet and exercise and the taking of fish oil supplements have all been seen to stave off heart failure. However, a group of researchers at Indiana University, Stanford University, the Charité University of Medicine Berlin in Germany and the University of Navarra in Spain have discovered a molecule that is a cause for heart failure, leading to a possible treatment that could keep the heart healthy, staving off the onset of cardiovascular disease.
According to UPI, the researchers found that an excess of something called a lysyl oxidase-like 2 molecule results in a fibrosis of the heart’s muscles, which causes them to thicken. The fibrosis causes the heart’s pumping of blood to be impeded, which in turn can lead to heart failure. If the molecule is reduced, the heart muscles repair themselves and start to function normally again.
The study suggests that a treatment could be devised that prevents or reduces the excess of this molecule, stopping and repairing damage to the heart muscle, thus preventing heart failure. The researchers now intend to start developing that treatment, which will be personalized for each patient.
According to the CDC, roughly 5.7 million adults in the United States have heart failure. Half of the people who are diagnosed with heart failure die within five years.
After extensive research and development, including clinical trials, doctors may have a new treatment that will fight a leading cause of death in the United States, lengthening lives and improving the quality of life.
Our strategy focuses on enabling our clients to recruit the right people for the structure in which they will perform. Please contact us to learn more about our expertise in Executive Search for Commercial Leadership positions in Medical Device and Biotechnology; including Marketing, Strategy, Sales Leadership, Training, Development, etc. We look forward to the opportunity to help you consistently improve your performance and your business!
Follow me on Twitter @PrimeCoreSearch.